Decoding Fibrothecal Tumors of the Ovary A Rare Yet Benign Ovarian Neoplasm

Introduction

Case Highlights and Clinical Insights

  • Patient Profile: 59-year-old, nulligravida, post-menopausal woman.
  • Symptoms: Pelvic pain, abdominal distension, fatigue, and weight loss.
  • Initial Assessment: Pelvic ultrasound indicated a solid-cystic ovarian mass (ORADS 4). Elevated CA-125 levels (1693.60 IU/ml).
  • Imaging Support: CT scan showed a large heterogeneous mass displacing adjacent organs with effusion but no metastases.

Surgical Approach and Histopathology

  • Procedure: Total hysterectomy with bilateral adnexectomy, omentectomy, and appendectomy.
  • Findings:
    • Right ovarian mass diagnosed as fibrothecoma.
    • Left adnexa revealed dystrophic changes but no malignancy.
    • Appendix displayed chronic inflammation.
    • Uterus showed benign myomas.
  • Follow-up: Scheduled at 1, 3, 6, and 12 months post-op; patient recovered uneventfully before being lost to follow-up after one year.

Diagnostic and Treatment Considerations

  • Origin & Behavior: Fibrothecal tumors originate from ovarian stromal tissue and are primarily benign.
  • Symptoms: Varying based on hormone secretion—estrogen-producing tumors may lead to endometrial hyperplasia.
  • Preferred Imaging:
    • Ultrasound – solid mass with regular contours.
    • MRI – hyposignal on T2-weighted sequences due to fibrous content.
    • CT Scan – useful for surgical planning.
  • Definitive Diagnosis: Relies on histopathological confirmation showing spindle cells within a collagenous stroma.

Clinical Implications & Broader Perspective

Read the Full Case Study

Further Reading & Related Resources

Call-to-Action

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference.Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.